High Sierra Technologies, Inc. (HSTI)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -238.36 Thousand USD | 6.86% |
| 2021 | -255.92 Thousand USD | 0.77% |
| 2020 | -257.91 Thousand USD | 44.25% |
| 2019 | -462.64 Thousand USD | -1227.92% |
| 2018 | -34.84 Thousand USD | -57.5% |
| 2017 | -22.12 Thousand USD | -7.07% |
| 2016 | -20.66 Thousand USD | 40.7% |
| 2015 | -34.84 Thousand USD | -244.29% |
| 2014 | 24.14 Thousand USD | 1.5% |
| 2013 | 23.78 Thousand USD | 4.5% |
| 2012 | 22.76 Thousand USD | 202.69% |
| 2011 | -22.16 Thousand USD | -22.81% |
| 2010 | -18.05 Thousand USD | 3.29% |
| 2009 | -18.66 Thousand USD | -4.3% |
| 2008 | -17.89 Thousand USD | -184.66% |
| 2007 | 21.13 Thousand USD | -29.01% |
| 2006 | 29.77 Thousand USD | 237.82% |
| 2005 | 8813.00 USD | 193.91% |
| 2004 | -9385.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -75.21 Thousand USD | -5.97% |
| 2023 Q2 | -77.11 Thousand USD | -2.52% |
| 2023 Q3 | -73.2 Thousand USD | 5.07% |
| 2022 Q1 | -97.93 Thousand USD | -414.93% |
| 2022 FY | -238.36 Thousand USD | 6.86% |
| 2022 Q4 | -70.98 Thousand USD | -103.54% |
| 2022 Q3 | -34.87 Thousand USD | -0.86% |
| 2022 Q2 | -34.57 Thousand USD | 64.69% |
| 2021 Q1 | -70.25 Thousand USD | 62.62% |
| 2021 Q4 | -19.01 Thousand USD | 84.08% |
| 2021 FY | -255.92 Thousand USD | 0.77% |
| 2021 Q2 | -47.22 Thousand USD | 32.78% |
| 2021 Q3 | -119.42 Thousand USD | -152.89% |
| 2020 Q1 | -17.39 Thousand USD | -140.51% |
| 2020 Q3 | -33.11 Thousand USD | -70.31% |
| 2020 Q2 | -19.44 Thousand USD | -11.82% |
| 2020 FY | -257.91 Thousand USD | 44.25% |
| 2020 Q4 | -187.95 Thousand USD | -467.51% |
| 2019 FY | -462.64 Thousand USD | -1227.92% |
| 2019 Q3 | -172.24 Thousand USD | 37.7% |
| 2019 Q1 | -56.82 Thousand USD | -33.65% |
| 2019 Q2 | -276.49 Thousand USD | -386.55% |
| 2019 Q4 | 42.92 Thousand USD | 124.92% |
| 2018 Q4 | -42.52 Thousand USD | -173.5% |
| 2018 Q1 | -90.00 USD | 97.36% |
| 2018 Q3 | 57.84 Thousand USD | 700.9% |
| 2018 Q2 | -9627.00 USD | -10596.67% |
| 2018 FY | -34.84 Thousand USD | -57.5% |
| 2017 Q3 | 3666.00 USD | -67.67% |
| 2017 FY | -22.12 Thousand USD | -7.07% |
| 2017 Q4 | -3414.00 USD | -193.13% |
| 2017 Q2 | 11.33 Thousand USD | 206.29% |
| 2017 Q1 | 3702.00 USD | 1.65% |
| 2016 Q4 | 3642.00 USD | -31.71% |
| 2016 Q3 | 5333.00 USD | -42.61% |
| 2016 FY | -20.66 Thousand USD | 40.7% |
| 2016 Q2 | 9293.00 USD | 287.85% |
| 2016 Q1 | 2396.00 USD | -56.74% |
| 2015 Q2 | 17.46 Thousand USD | 328.66% |
| 2015 Q1 | 4075.00 USD | -31.82% |
| 2015 Q4 | 5538.00 USD | -28.65% |
| 2015 FY | -34.84 Thousand USD | -244.29% |
| 2015 Q3 | 7762.00 USD | -55.56% |
| 2014 FY | 24.14 Thousand USD | 1.5% |
| 2014 Q4 | 5977.00 USD | 179.99% |
| 2014 Q3 | -7472.00 USD | -315.52% |
| 2014 Q2 | 3467.00 USD | -52.05% |
| 2014 Q1 | 7230.00 USD | 45.27% |
| 2013 Q1 | 2282.00 USD | -56.13% |
| 2013 Q2 | 10.81 Thousand USD | 373.75% |
| 2013 Q3 | 5719.00 USD | -47.1% |
| 2013 Q4 | 4977.00 USD | -12.97% |
| 2013 FY | 23.78 Thousand USD | 4.5% |
| 2012 FY | 22.76 Thousand USD | 202.69% |
| 2012 Q3 | 6735.00 USD | 33.23% |
| 2012 Q2 | 5055.00 USD | -12.45% |
| 2012 Q4 | 5202.00 USD | -22.76% |
| 2012 Q1 | 5774.00 USD | 191.46% |
| 2011 Q1 | 7055.00 USD | 280.11% |
| 2011 Q2 | 4670.00 USD | -33.81% |
| 2011 Q3 | 4130.00 USD | -11.56% |
| 2011 FY | -22.16 Thousand USD | -22.81% |
| 2011 Q4 | -6313.00 USD | -252.86% |
| 2010 Q3 | -3204.00 USD | 52.18% |
| 2010 Q2 | -6700.00 USD | -58.47% |
| 2010 Q1 | -4228.00 USD | -11.97% |
| 2010 FY | -18.05 Thousand USD | 3.29% |
| 2010 Q4 | -3917.00 USD | -22.25% |
| 2009 Q3 | -3384.00 USD | 33.19% |
| 2009 Q2 | -5065.00 USD | 21.34% |
| 2009 Q1 | -6439.00 USD | -111.88% |
| 2009 Q4 | -3776.00 USD | -11.58% |
| 2009 FY | -18.66 Thousand USD | -4.3% |
| 2008 Q1 | 5136.00 USD | 70.18% |
| 2008 Q4 | -3039.00 USD | -198.93% |
| 2008 Q3 | 3072.00 USD | -53.79% |
| 2008 Q2 | 6648.00 USD | 29.44% |
| 2008 FY | -17.89 Thousand USD | -184.66% |
| 2007 Q1 | -6756.00 USD | -392.97% |
| 2007 Q2 | 8467.00 USD | 225.33% |
| 2007 FY | 21.13 Thousand USD | -29.01% |
| 2007 Q3 | 2896.00 USD | -65.8% |
| 2007 Q4 | 3018.00 USD | 4.21% |
| 2006 Q4 | 2306.00 USD | -72.89% |
| 2006 Q3 | 8506.00 USD | -53.4% |
| 2006 Q1 | -1017.00 USD | 75.37% |
| 2006 FY | 29.77 Thousand USD | 237.82% |
| 2006 Q2 | 18.25 Thousand USD | 1894.79% |
| 2005 Q1 | -1364.00 USD | 0.0% |
| 2005 Q2 | -5565.00 USD | -307.99% |
| 2005 Q3 | -1359.00 USD | 75.58% |
| 2005 Q4 | -4129.00 USD | -203.83% |
| 2005 FY | 8813.00 USD | 193.91% |
| 2004 FY | -9385.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BioQuest Corp. | -89.76 USD | -265457.041% |
| GSRX Industries Inc. | - USD | Infinity% |
| Instadose Pharma Corp. | - USD | Infinity% |